Literature DB >> 12050290

Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene.

Peter Igaz, Attila Patócs, Károly Rácz, Izabella Klein, András Váradi, Olga Esik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050290     DOI: 10.1210/jcem.87.6.8623

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 2.  Multiple endocrine neoplasia type 2.

Authors:  Mariola Peczkowska; Andrzej Januszewicz
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 3.  Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.

Authors:  Samuel A Wells; Furio Pacini; Bruce G Robinson; Massimo Santoro
Journal:  J Clin Endocrinol Metab       Date:  2013-06-06       Impact factor: 5.958

4.  Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer.

Authors:  Attila Patocs; Izabella Klein; Aniko Szilvasi; Peter Gergics; Miklos Toth; Zsuzsa Valkusz; Erzsebet Forizs; Peter Igaz; Yousuf Al-Farhat; Attila Tordai; Andras Varadi; Karoly Racz; Olga Esik
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

Review 5.  RET codon 609 mutations: a contribution for better clinical managing.

Authors:  Caterina Mian; Paola Sartorato; Susi Barollo; Mariangela Zane; Giuseppe Opocher
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.